The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Martin H. Cohen

Division of Biological Oncology Products

Office of Oncology Drug Products

Center for Drug Evaluation and Research

US Food and Drug Administration

USA

[email]@cder.fda.gov

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Division of Biological Oncology Products, Office of Oncology Drug Products, Center for Drug Evaluation and Research, US Food and Drug Administration, USA. 2003 - 2007

References

  1. FDA drug approval summary: bevacizumab plus FOLFOX4 as second-line treatment of colorectal cancer. Cohen, M.H., Gootenberg, J., Keegan, P., Pazdur, R. Oncologist (2007) [Pubmed]
  2. U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval. Cohen, M.H., Johnson, J.R., Pazdur, R. Clin. Cancer Res. (2005) [Pubmed]
  3. FDA drug approval summary: pemetrexed for injection (Alimta) for the treatment of non-small cell lung cancer. Cohen, M.H., Johnson, J.R., Wang, Y.C., Sridhara, R., Pazdur, R. Oncologist (2005) [Pubmed]
  4. FDA drug approval summary: erlotinib (Tarceva) tablets. Cohen, M.H., Johnson, J.R., Chen, Y.F., Sridhara, R., Pazdur, R. Oncologist (2005) [Pubmed]
  5. Food and Drug Administration Drug approval summary: temozolomide plus radiation therapy for the treatment of newly diagnosed glioblastoma multiforme. Cohen, M.H., Johnson, J.R., Pazdur, R. Clin. Cancer Res. (2005) [Pubmed]
  6. United States Food and Drug Administration Drug Approval summary: Gefitinib (ZD1839; Iressa) tablets. Cohen, M.H., Williams, G.A., Sridhara, R., Chen, G., McGuinn, W.D., Morse, D., Abraham, S., Rahman, A., Liang, C., Lostritto, R., Baird, A., Pazdur, R. Clin. Cancer Res. (2004) [Pubmed]
  7. FDA drug approval summary: gefitinib (ZD1839) (Iressa) tablets. Cohen, M.H., Williams, G.A., Sridhara, R., Chen, G., Pazdur, R. Oncologist (2003) [Pubmed]
 
WikiGenes - Universities